DK2872497T4 - Chromanyl-derivater til behandling af mitokondriel sygdom - Google Patents
Chromanyl-derivater til behandling af mitokondriel sygdom Download PDFInfo
- Publication number
- DK2872497T4 DK2872497T4 DK13759838T DK13759838T DK2872497T4 DK 2872497 T4 DK2872497 T4 DK 2872497T4 DK 13759838 T DK13759838 T DK 13759838T DK 13759838 T DK13759838 T DK 13759838T DK 2872497 T4 DK2872497 T4 DK 2872497T4
- Authority
- DK
- Denmark
- Prior art keywords
- mitocondal
- disease
- treatment
- chromanyl
- derivatives
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670644P | 2012-07-12 | 2012-07-12 | |
| EP12176128 | 2012-07-12 | ||
| PCT/NL2013/050528 WO2014011047A1 (en) | 2012-07-12 | 2013-07-12 | Chromanyl derivatives for treating mitochondrial disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK2872497T3 DK2872497T3 (da) | 2017-04-24 |
| DK2872497T4 true DK2872497T4 (da) | 2019-11-25 |
Family
ID=49916367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13759838T DK2872497T4 (da) | 2012-07-12 | 2013-07-12 | Chromanyl-derivater til behandling af mitokondriel sygdom |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2872497B2 (da) |
| JP (1) | JP6292721B2 (da) |
| KR (1) | KR102137450B1 (da) |
| CN (1) | CN104662011B (da) |
| AU (1) | AU2013287347B2 (da) |
| CA (1) | CA2878567C (da) |
| DK (1) | DK2872497T4 (da) |
| ES (1) | ES2622190T5 (da) |
| HU (1) | HUE033757T2 (da) |
| LT (1) | LT2872497T (da) |
| PL (1) | PL2872497T5 (da) |
| PT (1) | PT2872497T (da) |
| RS (1) | RS55813B2 (da) |
| SI (1) | SI2872497T2 (da) |
| SM (1) | SMT201700195T1 (da) |
| WO (1) | WO2014011047A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3154694B1 (en) | 2014-06-13 | 2025-01-29 | Children's Medical Center Corporation | Products and methods to isolate mitochondria |
| PL3297625T3 (pl) | 2015-05-22 | 2022-11-14 | Sulfateq B.V. | Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek |
| WO2016190852A1 (en) * | 2015-05-26 | 2016-12-01 | Stealth Peptides International, Inc. | Therapeutic compositions including chromanyl compounds, variants and analogues thereof, and uses thereof |
| ES3033538T3 (en) * | 2015-10-08 | 2025-08-05 | Khondrion Ip B V | Novel compounds for treating mitochondrial disease |
| ES3057779T3 (en) * | 2016-01-15 | 2026-03-04 | Childrens Medical Ct Corp | Therapeutic use of mitochondria and combined mitochondrial agents |
| KR101816277B1 (ko) | 2016-10-06 | 2018-01-08 | 가천대학교 산학협력단 | 8-옥소-데옥시구아노신(8-oxo-2'-deoxyguanosine) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 각막 손상 치료용 약학적 조성물 |
| WO2018184706A1 (en) | 2017-04-05 | 2018-10-11 | Khondrion Ip B.V. | Novel treatment of mitochondrial diseases |
| US11357767B2 (en) | 2017-11-22 | 2022-06-14 | Khondrion Ip B.V. | Compounds for use in treating depression and migraine |
| CA3079483A1 (en) | 2017-11-22 | 2019-05-31 | Khondrion Ip B.V. | Compounds as mpges-1 inhibitors |
| EP3914239A1 (en) | 2019-01-25 | 2021-12-01 | Universitat Autònoma de Barcelona | Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases |
| IL291898A (en) * | 2019-10-04 | 2022-06-01 | Stealth Biotherapeutics Inc | Quinone-, hydroquinone- and naphthoquinone-analogues of vatiquinone for treatment of mitochondrial disorder diseases |
| NL2024431B1 (en) * | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
| WO2021202986A1 (en) | 2020-04-03 | 2021-10-07 | Stealth Biotherapeutics Corp | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia |
| NL2025730B1 (en) | 2020-06-02 | 2022-01-20 | Sulfateq Bv | Compounds for treatment of sepsis |
| NL2026511B1 (en) | 2020-09-21 | 2022-05-24 | Sulfateq Bv | Compounds for treatment of heart failure |
| NL2031091B1 (en) | 2022-02-28 | 2023-09-07 | Sulfateq Bv | Chromanol compounds for treatment or prophylaxis of ageing and ageing-associated disorders |
| WO2025242849A1 (en) | 2024-05-24 | 2025-11-27 | Khondrion Ip B.V. | Chromanyl derivatives for use in the treatment of bone disorders |
| EP4729606A1 (en) | 2024-10-17 | 2026-04-22 | Sulfateq B.V. | Methods for the cryopreservation of cells |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1338012C (en) | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
| JPH02250831A (ja) * | 1989-03-23 | 1990-10-08 | Kuraray Co Ltd | 3,4―ジヒドロ―2h―ベンゾピラン誘導体及びそれを有効成分とする抗消化性潰瘍剤 |
| FR2676056B1 (fr) | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JP3093170B2 (ja) * | 1996-09-19 | 2000-10-03 | 株式会社ジャパンエナジー | ヒドロキノン誘導体及びその医薬用途 |
| FR2764889B1 (fr) * | 1997-06-20 | 2000-09-01 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| FR2761066B1 (fr) * | 1997-03-24 | 2000-11-24 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| JPH11106371A (ja) * | 1997-07-04 | 1999-04-20 | Nisshin Flour Milling Co Ltd | アシルヒドラゾン誘導体 |
| AR019190A1 (es) * | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
| EP1101759A4 (en) * | 1998-07-31 | 2001-12-12 | Nippon Soda Co | PHENYLAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICATIONS FOR HYPERLIPEMY |
| FR2783519B1 (fr) * | 1998-09-23 | 2003-01-24 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| WO2001081324A1 (de) * | 2000-04-25 | 2001-11-01 | Schering Aktiengesellschaft | Benzoxazin- und benzothiazin-derivate mit nos-inhibitorischen und antioxidativen eigenschaften |
| GR1003725B (el) | 2000-07-12 | 2001-11-27 | Νεες ενωσεις με συνδυασμενη αντιοξειδωτικη και αντιαρρυθμικη δραση | |
| JP2002047272A (ja) * | 2000-07-26 | 2002-02-12 | Dai Ichi Seiyaku Co Ltd | ポリアミンアミド誘導体 |
| NZ513547A (en) | 2001-08-13 | 2002-09-27 | Antipodean Biotechnology Ltd | Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone) |
| JP2003212872A (ja) * | 2002-01-23 | 2003-07-30 | Japan Energy Corp | 新規クロマン誘導体及びその医薬用途 |
| GB0204232D0 (en) | 2002-02-22 | 2002-04-10 | Isis Innovation | Assay |
| WO2005012293A1 (ja) * | 2003-08-01 | 2005-02-10 | Nippon Soda Co., Ltd. | フェニルアゾール化合物、製造法および抗酸化薬 |
| CA2580584C (en) | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| JP2008019188A (ja) * | 2006-07-11 | 2008-01-31 | Hamari Chemicals Ltd | 新規カルノシン誘導体及び組成物 |
| EP3018122B1 (en) * | 2007-11-06 | 2018-10-10 | BioElectron Technology Corporation | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| SG187744A1 (en) | 2010-08-06 | 2013-03-28 | Edison Pharmaceuticals Inc | Treatment of mitochondrial diseases with naphthoquinones |
| US20140031432A1 (en) | 2010-08-06 | 2014-01-30 | Ampere Life Sciences, Inc. | Treatment of mitochondrial diseases with vitamin k |
| NL2010010C2 (en) | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
-
2013
- 2013-07-12 CN CN201380037183.8A patent/CN104662011B/zh active Active
- 2013-07-12 CA CA2878567A patent/CA2878567C/en active Active
- 2013-07-12 HU HUE13759838A patent/HUE033757T2/en unknown
- 2013-07-12 AU AU2013287347A patent/AU2013287347B2/en active Active
- 2013-07-12 LT LTEP13759838.9T patent/LT2872497T/lt unknown
- 2013-07-12 PT PT137598389T patent/PT2872497T/pt unknown
- 2013-07-12 ES ES13759838T patent/ES2622190T5/es active Active
- 2013-07-12 RS RS20170348A patent/RS55813B2/sr unknown
- 2013-07-12 SI SI201330603T patent/SI2872497T2/sl unknown
- 2013-07-12 KR KR1020157000618A patent/KR102137450B1/ko active Active
- 2013-07-12 EP EP13759838.9A patent/EP2872497B2/en active Active
- 2013-07-12 DK DK13759838T patent/DK2872497T4/da active
- 2013-07-12 JP JP2015521570A patent/JP6292721B2/ja active Active
- 2013-07-12 SM SM20170195T patent/SMT201700195T1/it unknown
- 2013-07-12 PL PL13759838T patent/PL2872497T5/pl unknown
- 2013-07-12 WO PCT/NL2013/050528 patent/WO2014011047A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2878567C (en) | 2021-02-23 |
| AU2013287347A1 (en) | 2015-01-22 |
| AU2013287347B2 (en) | 2017-11-30 |
| KR20150036035A (ko) | 2015-04-07 |
| ES2622190T5 (es) | 2020-04-23 |
| CA2878567A1 (en) | 2014-01-16 |
| DK2872497T3 (da) | 2017-04-24 |
| PT2872497T (pt) | 2017-04-24 |
| LT2872497T (lt) | 2017-04-25 |
| PL2872497T5 (pl) | 2020-02-28 |
| RS55813B2 (sr) | 2019-12-31 |
| JP6292721B2 (ja) | 2018-03-14 |
| RS55813B1 (sr) | 2017-08-31 |
| SMT201700195T1 (it) | 2017-05-08 |
| PL2872497T3 (pl) | 2017-07-31 |
| CN104662011A (zh) | 2015-05-27 |
| SI2872497T1 (sl) | 2017-08-31 |
| EP2872497B2 (en) | 2019-10-09 |
| KR102137450B1 (ko) | 2020-07-27 |
| EP2872497A1 (en) | 2015-05-20 |
| CN104662011B (zh) | 2017-09-29 |
| SI2872497T2 (sl) | 2019-12-31 |
| EP2872497B1 (en) | 2017-03-08 |
| JP2015522067A (ja) | 2015-08-03 |
| ES2622190T3 (es) | 2017-07-05 |
| WO2014011047A1 (en) | 2014-01-16 |
| HUE033757T2 (en) | 2017-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022027I1 (el) | Παραγωγα βενζιμιδαζολο-προλινης | |
| IL289300A (en) | Combination therapy for treating cancer | |
| LTC2785706I2 (lt) | Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui | |
| CY2019033I1 (el) | Μακροκυκλικα παραγωγα για την αγωγη υπερπλαστικων παθησεων | |
| LT2885010T (lt) | Tautopatijos gydymo būdai | |
| DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
| DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK3470063T3 (da) | Farmaceutiske sammensætninger til behandling af cftr-medierede sygdomme | |
| DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
| DK2846809T3 (da) | Behandling af myelosuppression | |
| PL2872497T3 (pl) | Pochodne chromanylowe do leczenia choroby mitochondrialnej | |
| HUE037048T2 (hu) | Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására | |
| PT2684880T (pt) | Derivado de dispiropirrolidina | |
| DK2814849T3 (da) | Fremgangsmåde til fremstilling af cyclodextrin-derivater | |
| DK2717941T3 (da) | Behandling af cancer | |
| HUE048876T2 (hu) | Rákos megbetegedések kezelése | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| PL2739153T3 (pl) | Leczenie raka sutka | |
| EP2935546A4 (en) | BIORAFFINATION OF RAW TALL OIL | |
| DK2785349T4 (da) | Kombinationsbehandling af cancer | |
| DK2701733T3 (da) | Forbindelser til behandling af neuropsykiatriske forstyrrelser | |
| DK2903967T3 (da) | Acylaminopyrimidinderivater til behandling af virusinfektioner og yderligere sygdomme | |
| EP2665431C0 (en) | Drug delivery technology | |
| CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona |